TFS CAPITAL LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 216 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$854,000
+196.5%
27,291
+44.6%
0.28%
+575.6%
Q1 2016$288,000
-68.1%
18,871
-70.7%
0.04%
-52.9%
Q3 2015$903,000
-18.4%
64,396
-1.2%
0.09%
-19.4%
Q2 2015$1,107,000
-36.2%
65,169
-54.6%
0.11%
-36.5%
Q1 2015$1,735,000
-49.4%
143,529
-65.3%
0.17%
-48.0%
Q4 2014$3,432,000
+285.2%
413,512
+303.4%
0.33%
+324.7%
Q3 2014$891,000102,5150.08%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders